{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:54:58Z","timestamp":1793037298085,"version":"4.5.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["99001055"],"award-info":[{"award-number":["99001055"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.KMU.REC.1400.067"],"award-info":[{"award-number":["IR.KMU.REC.1400.067"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jconrel.2022.02.015","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:25:01Z","timestamp":1645097101000},"page":"777-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles"],"prefix":"10.1016","volume":"343","author":[{"given":"Alireza","family":"Poustforoosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hashemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Pardakhty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.02.015_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.reprotox.2017.06.043","article-title":"The great barrier belief: the blood\u2013brain barrier and considerations for juvenile toxicity studies","volume":"72","author":"Schmitt","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.neuro.2011.12.009","article-title":"Barriers in the developing brain and neurotoxicology","volume":"33","author":"Ek","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2016.03.014","article-title":"Antibody therapies in CNS diseases","volume":"120","author":"Freskg\u00e5rd","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0025","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0045","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.7150\/thno.21254","article-title":"Current strategies for brain drug delivery","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0050","article-title":"3D-QSAR, molecular docking, molecular dynamics, and ADME\/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma","author":"Poustforoosh","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0070","doi-asserted-by":"crossref","first-page":"41316","DOI":"10.1038\/srep41316","article-title":"Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acscombsci.6b00116","article-title":"Rationally designed peptides and peptidomimetics as inhibitors of amyloid-\u03b2 (A\u03b2) aggregation: potential therapeutics of Alzheimer\u2019s disease","volume":"19","author":"Goyal","year":"2017","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0085","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood\u2013brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0090","series-title":"Vitalf\u00e4rbung am Zentralnervensystem: Beitrag zur Physio-Pathologie des Plexus chorioideus und der Hirnh\u00e4ute","author":"Goldmann","year":"1913"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1083\/jcb.34.1.207","article-title":"Fine structural localization of a blood-brain barrier to exogenous peroxidase","volume":"34","author":"Reese","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood\u2013brain barrier: an overview","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood\u2013brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0140","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood\u2013brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCRESAHA.116.306534","article-title":"Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability","volume":"120","author":"Komarova","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0160","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-005-5371-1","article-title":"Mammalian lactoferrin receptors: structure and function","volume":"62","author":"Suzuki","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10717540601067471","article-title":"Preparation and characterization of a novel nonviral gene transfer system: procationic-liposome-protamine-DNA complexes","volume":"14","author":"Zhong","year":"2007","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120351","article-title":"Evolving new-age strategies to transport therapeutics across the blood-brain-barrier","volume":"599","author":"Choudhari","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0180","first-page":"1","article-title":"Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity, Nature","volume":"5","author":"Yao","year":"2014","journal-title":"Communications"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0185","doi-asserted-by":"crossref","first-page":"35108","DOI":"10.1038\/srep35108","article-title":"Analysis of the brain mural cell transcriptome","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0190","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0195","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cne.903020414","article-title":"On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immunohistochemistry of connexin43 expression","volume":"302","author":"Yamamoto","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0200","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jnc.13923","article-title":"An isogenic blood\u2013brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells","volume":"140","author":"Canfield","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183298","article-title":"Tight junction modulation at the blood-brain barrier: current and future perspectives","volume":"1862","author":"Hashimoto","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0210","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2174\/138161206777947722","article-title":"Structure and function of the intercellular junctions: barrier of paracellular drug delivery","volume":"12","author":"Zheng","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/nyas.13378","article-title":"Architecture of the paracellular channels formed by claudins of the blood\u2013brain barrier tight junctions","volume":"1405","author":"Irudayanathan","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0220","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0225","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0230","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","article-title":"Blood\u2013brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery","volume":"19","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0235","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3389\/fneur.2021.749047","article-title":"Focused ultrasound mediated opening of the blood-brain barrier for neurodegenerative diseases","volume":"12","author":"Fishman","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0240","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","article-title":"Crystal structure of the human glucose transporter GLUT1","volume":"510","author":"Deng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1152\/ajplegacy.1976.230.1.94","article-title":"Amino acid assignment to one of three blood brain barrier amino acid carriers","volume":"230","author":"Oldendorf","year":"1976","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0255","first-page":"C1101","article-title":"Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal","volume":"274","author":"Lee","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0260","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","article-title":"Supply and demand in cerebral energy metabolism: the role of nutrient transporters","volume":"27","author":"Simpson","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0265","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1172\/JCI70324","article-title":"Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis","volume":"124","author":"Mayerl","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jconrel.2022.02.015_bb0270","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1210\/en.2008-0378","article-title":"Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier","volume":"149","author":"Roberts","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0275","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0280","first-page":"735","article-title":"Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells","volume":"117","author":"Mitchell","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0285","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1139\/o98-095","article-title":"Recent advances in the molecular biology of nucleoside transporters of mammalian cells","volume":"76","author":"Cass","year":"1998","journal-title":"Biochem. Cell Biol. Biochim Biol. Cell."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0290","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/jcbfm.2014.4","article-title":"Hypoxia\/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery","volume":"34","author":"Thompson","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0295","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","article-title":"Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS","volume":"467","author":"Gao","year":"2015","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)20567-5","article-title":"Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo","volume":"259","author":"Pardridge","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0310","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.xphs.2017.04.036","article-title":"Regulation of tight-junction integrity by insulin in an in vitro model of human blood\u2013brain barrier","volume":"106","author":"Ito","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1471-4159.1989.tb07340.x","article-title":"Low-density lipoprotein receptor on endothelium of brain capillaries","volume":"53","author":"M\u00e9resse","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0325","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038149","article-title":"Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models","volume":"7","author":"Urich","year":"2012","journal-title":"PLoS One"},{"issue":"2008","key":"10.1016\/j.jconrel.2022.02.015_bb0335","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform \u2013 specific disruption of amyloid \u03b2 peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0340","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.apsb.2014.03.001","article-title":"Brain tumor-targeted drug delivery strategies","volume":"4","author":"Wei","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0355","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1357-2725(99)00070-9","article-title":"The transferrin receptor: role in health and disease","volume":"31","author":"Ponka","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0360","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0365","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(85)90423-8","article-title":"Blood-brain barrier permeability to leucine-enkephalin, d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine)","volume":"336","author":"Zlokovic","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrd4522","article-title":"Biologics: transferrin\u2019 bispecific antibodies across the blood-brain barrier","volume":"14","author":"Bray","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0375","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1210\/endo.141.4.7435","article-title":"Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier","volume":"141","author":"Zlokovic","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0380","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0390","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A role for P-glycoprotein in clearance of Alzheimer amyloid? -Peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0395","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-\u03b2 deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6336(88)80001-9","article-title":"Ultrastructural cytochemistry of blood-brain barrier endothelia","volume":"18","author":"Vorbrodt","year":"1988","journal-title":"Prog. Histochem. Cytochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2015.04.031","article-title":"Contrasting effects of Na+, K+-ATPase activation on seizure activity in acute versus chronic models","volume":"298","author":"Funck","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0410","doi-asserted-by":"crossref","first-page":"O23","DOI":"10.1186\/2050-6511-14-S1-O23","article-title":"Elementary Ca2+signals through endothelial TRPV4 channels regulate vascular function","volume":"14","author":"Nelson","year":"2013","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0415","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0420","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nn.4533","article-title":"Capillary K+-sensing initiates retrograde hyperpolarization to increase local cerebral blood flow","volume":"20","author":"Longden","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0425","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00424-007-0377-1","article-title":"Kv1 and Kir2 potassium channels are expressed in rat brain endothelial cells","volume":"456","author":"Millar","year":"2008","journal-title":"Arch. Eur. J. Physiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0430","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2016.05.131","article-title":"Hypoxic stress up-regulates Kir2.1 expression and facilitates cell proliferation in brain capillary endothelial cells","volume":"476","author":"Yamamura","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0435","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1113\/jphysiol.2006.117374","article-title":"Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells","volume":"576","author":"Taylor","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0440","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0271678X15616138","article-title":"Ion channel networks in the control of cerebral blood flow","volume":"36","author":"Longden","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0445","doi-asserted-by":"crossref","first-page":"225","DOI":"10.15171\/bi.2016.30","article-title":"Blood-brain barrier transport machineries and targeted therapy of brain diseases","volume":"6","author":"Barar","year":"2016","journal-title":"BioImpacts"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0450","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0455","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-019-00653-z","article-title":"Recent expansions on cellular models to uncover the scientific barriers towards drug development for Alzheimer\u2019s disease","volume":"39","author":"Dubey","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0460","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/IJN.S210876","article-title":"Recent expansions of novel strategies towards the drug targeting into the brain","volume":"14","author":"Alexander","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0465","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/1061186X.2015.1029930","article-title":"Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor","volume":"23","author":"Garg","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15171\/bi.2016.07","article-title":"Advanced drug delivery and targeting technologies for the ocular diseases","volume":"6","author":"Barar","year":"2016","journal-title":"BioImpacts"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","article-title":"Transmission of \u03b1-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson\u2019s disease?","volume":"5","author":"Matsumoto","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01181571","article-title":"Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers","volume":"22","author":"Villegas","year":"1993","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(97)00597-3","article-title":"HIV-1 protein GP120 crosses the blood-brain barrier: role of adsorptive endocytosis","volume":"61","author":"Banks","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","article-title":"Drug targeting to the brain","volume":"47","author":"de Boer","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0500","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0006-291X(88)81333-0","article-title":"Liposome targeting to mouse brain: Mannose as a recognition marker","volume":"153","author":"Umezawa","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0505","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3932","article-title":"Pericyte loss influences Alzheimer-like neurodegeneration in mice","volume":"4","author":"Sagare","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013741","article-title":"The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells","volume":"5","author":"Daneman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0515","doi-asserted-by":"crossref","DOI":"10.1096\/fj.05-4944fje","article-title":"Microarray analysis of blood microvessels from PDGF-B and PDGF-R\u03b2 mutant mice identifies novel markers for brain pericytes","volume":"20","author":"Bondjers","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0520","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.301.3.838","article-title":"Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels","volume":"301","author":"Ningaraj","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0525","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/17425247.2012.682726","article-title":"Recent advances in brain tumor-targeted nano-drug delivery systems","volume":"9","author":"Liu","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0530","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.12.020","article-title":"Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect","volume":"143","author":"Zhan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0535","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0540","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive In situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0545","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2010.05.003","article-title":"Strategy for effective brain drug delivery","volume":"40","author":"Alam","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117540","article-title":"Insulin mediated novel therapies for the treatment of Alzheimer\u2019s disease","volume":"249","author":"Dubey","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0555","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2005.09.053","article-title":"Barriers to carrier mediated drug and gene delivery to brain tumors","volume":"110","author":"Huynh","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0560","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0565","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1022592913323","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates","volume":"61","author":"Patel","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0570","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.cgt.7700437","article-title":"Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors","volume":"9","author":"Abe","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0575","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(03)00043-1","article-title":"Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport","volume":"60","author":"Borlongan","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0580","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature02072","article-title":"Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion","volume":"425","author":"Prinz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0585","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4103\/1673-5374.241458","article-title":"Nose-to-brain drug delivery approach: a key to easily accessing the brain for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Alexander","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0590","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0595","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jps.20318","article-title":"Nasal drug administration: potential for targeted central nervous system delivery","volume":"94","author":"Graff","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0600","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0605","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","volume":"16","author":"Ali","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1254\/jjp.87.97","article-title":"Brain drug targeting and gene technologies","volume":"87","author":"Pardridge","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0615","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: the vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0620","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood-brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0625","first-page":"406","article-title":"Carriers for prodrug synthesis: a review","volume":"81","author":"Gandhi","year":"2019","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0630","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/1098-1128(200009)20:5<367::AID-MED3>3.0.CO;2-P","article-title":"Targeting drugs to the brain by redox chemical delivery systems","volume":"20","author":"Prokai","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0635","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1016\/j.bmc.2016.09.038","article-title":"Sobetirome prodrug esters with enhanced blood\u2013brain barrier permeability","volume":"24","author":"Placzek","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0640","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmc.2017.03.047","article-title":"Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration","volume":"25","author":"Ferrara","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0645","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules23010040","article-title":"Dopamine and levodopa prodrugs for the treatment of Parkinson\u2019s disease","volume":"23","author":"Haddad","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0650","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood\u2013brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0655","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/0006-2952(90)90577-8","article-title":"Targeting of antiviral drugs to T4-lymphocytes. anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro","volume":"40","author":"Molema","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2017.00086","article-title":"Increasing of blood-brain tumor barrier permeability through transcellular and paracellular pathways by microbubble-enhanced diagnostic ultrasound in a C6 glioma model","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0665","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","article-title":"Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium","volume":"34","author":"Sheikov","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0670","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2018.12.009","article-title":"Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes","volume":"295","author":"Papachristodoulou","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0675","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/pharmaceutics13122014","article-title":"Current and emerging strategies for enhancing antibody delivery to the brain","volume":"13","author":"Bajracharya","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0680","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fbioe.2020.579536","article-title":"Insight into nanoliposomes as smart nanocarriers for greening the twenty-first century biomedical settings","volume":"8","author":"Aguilar-P\u00e9rez","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0685","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.xphs.2020.05.008","article-title":"Smart ultrasound-triggered doxorubicin-loaded nanoliposomes with improved therapeutic response: a comparative study","volume":"109","author":"Shalaby","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0690","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/abd3cb","article-title":"Potential anticancer activity of a new pro-apoptotic peptide-thioctic acid gold nanoparticle platform","volume":"32","author":"Akrami","year":"2021","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0695","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-bioeng-071910-124709","article-title":"In vivo delivery of RNAi with lipid-based nanoparticles","volume":"13","author":"Huang","year":"2011","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0700","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nano.2019.01.014","article-title":"Effective encapsulation of apomorphine into biodegradable polymeric nanoparticles through a reversible chemical bond for delivery across the blood\u2013brain barrier","volume":"17","author":"Tan","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0705","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1021\/acschemneuro.9b00343","article-title":"Design and biological evaluation of lipoprotein-based donepezil nanocarrier for enhanced brain uptake through oral delivery","volume":"10","author":"Krishna","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0710","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/acs.molpharmaceut.8b00537","article-title":"Boosted memory and improved brain bioavailability of rivastigmine: targeting effort to the brain using covalently tethered lower generation PAMAM dendrimers with lactoferrin","volume":"15","author":"Gothwal","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0715","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1039\/C9NA00056A","article-title":"Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere\u2013cationic folate nanoconjugate","volume":"1","author":"Kumar Elechalawar","year":"2019","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0720","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer\u2019s disease","volume":"190","year":"2019","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0725","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.2147\/IJN.S199624","article-title":"The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies","volume":"14","author":"Dibaei","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0730","first-page":"541","article-title":"Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats, DARU","volume":"27","author":"Pailla","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0735","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/03639045.2019.1569039","article-title":"Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement","volume":"45","author":"Karami","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0740","series-title":"57. Jahrestagung Der Deutschen Gesellschaft F\u00fcr Nuklearmedizin","article-title":"MMP-responsive nanogels for delivery of radiopharmaceuticals across the blood brain barrier","author":"Morgenroth","year":"2019"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0745","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.2147\/IJN.S214585","article-title":"Delivery luteolin with folacin-modified nanoparticle for glioma therapy","volume":"14","author":"Wu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0750","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7150\/ntno.23125","article-title":"Functionalised carbon nanotubes enhance brain delivery of amyloid-targeting pittsburgh compound b (Pib)-derived ligands","volume":"2","author":"Costa","year":"2018","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0755","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2016.01.031","article-title":"Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo","volume":"225","author":"Kafa","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0760","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2217\/nnm-2019-0298","article-title":"Hampering brain tumor proliferation and migration using peptide nanofiber:siPLK1\/MMP2 complexes","volume":"14","author":"Mazza","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0765","series-title":"Proceedings \u2013 IEEE International Conference on Robotics and Automation","first-page":"727","article-title":"Towards MR-navigable nanorobotic carriers for drug delivery into the brain","author":"Tabatabaei","year":"2012"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0770","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2019.09.017","article-title":"Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier","volume":"519","author":"He","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0775","series-title":"Surface Modification of Nanoparticles for Targeted Drug Delivery","first-page":"245","article-title":"Successful delivery of zidovudine-loaded docosanol nanostructured lipid carriers (Docosanol NLCs) into rat brain","author":"Chakraborty","year":"2019"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119033","article-title":"Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity","volume":"577","author":"Khan","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0785","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(00)00639-6","article-title":"The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles","author":"Gessner","year":"2001","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0790","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0795","doi-asserted-by":"crossref","first-page":"81001","DOI":"10.18632\/oncotarget.20944","article-title":"PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0800","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2005.07.013","article-title":"Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier","volume":"108","author":"Costantino","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.03.008","article-title":"Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution","volume":"145","author":"Tosi","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0810","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pharmaceutics12010072","article-title":"PLGA-PEG-Ang\u20132 nanoparticles for blood\u2013brain barrier crossing: proof-of-concept study","volume":"12","author":"Hoyos-Ceballos","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0815","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1016\/j.biomaterials.2013.07.075","article-title":"Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment","volume":"34","author":"Cui","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0820","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0250-474X.25707","article-title":"Vesicular systems: an overview","volume":"68","author":"Biju","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0825","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.2147\/IJN.S318416","article-title":"Phytosomes as innovative delivery systems for phytochemicals: a comprehensive review of literature","volume":"16","author":"Barani","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0830","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejpb.2017.07.010","article-title":"Recent advances on extracellular vesicles in therapeutic delivery: challenges, solutions, and opportunities","volume":"119","author":"Lu","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12090855","article-title":"Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery","volume":"12","author":"Opatha","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0840","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0190-9","article-title":"New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes","volume":"5","author":"Amacker","year":"2020","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194179","article-title":"Niosomes, an alternative for liposomal delivery","volume":"13","author":"Bartelds","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0850","doi-asserted-by":"crossref","first-page":"49463","DOI":"10.1039\/C7RA07834J","article-title":"Changes in physical and chemical properties of niosome membrane induced by cholesterol: a promising approach for niosome bilayer intervention","volume":"7","author":"Nematollahi","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0855","first-page":"1781","article-title":"Ternary complex of plasmid DNA with NLS-Mu-Mu protein and cationic niosome for biocompatible and efficient gene delivery: a comparative study with protamine and lipofectamine","volume":"46","author":"Nematollahi","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0860","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-8118-10-4","article-title":"Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells","volume":"10","author":"Haqqani","year":"2013","journal-title":"Fluids Barr. CNS."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0870","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Alexander, Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/469679","article-title":"Liposomes for targeted delivery of active agents against neurodegenerative diseases (Alzheimer\u2019s disease and Parkinson\u2019s disease)","volume":"2011","author":"Spuch","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0880","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.2147\/IJN.S183117","article-title":"Liposome delivery systems for the treatment of Alzheimer\u2019s disease","volume":"13","author":"Ross","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0885","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0890","first-page":"166","article-title":"Comprehensive evaluation of gene expression in negative and positive trigger-based targeting niosomes in HEK-293 cell line","volume":"19","author":"Barani","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0895","article-title":"Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier","volume":"2018","author":"Gharbavi","year":"2018","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0900","first-page":"1","article-title":"Nanoliposomal formulation of pistachio hull extract: preparation, characterization and anti-cancer evaluation through Bax\/Bcl2 modulation","volume":"2022","author":"Harandi","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0905","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"Guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1849543518805355","article-title":"Smart niosomes of temozolomide for enhancement of brain targeting","volume":"5","author":"De","year":"2018","journal-title":"Nanobiomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0915","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2231-4040.85524","article-title":"Transferosomes \u2013 a vesicular transdermal delivery system for enhanced drug permeation","volume":"2","author":"Rajan","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0920","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0925","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1208\/s12249-019-1353-8","article-title":"Nanosized transferosome-based intranasal in situ gel for brain targeting of resveratrol: formulation, optimization, in vitro evaluation, and in vivo pharmacokinetic study","volume":"20","author":"Salem","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0930","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbrc.2020.10.054","article-title":"Niosomal virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier","volume":"534","author":"Asadikaram","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0935","article-title":"Targeted delivery of CRISPR\/Cas13 as a promising therapeutic approach to treat SARS-CoV-2","volume":"21","author":"Goudarzi","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0940","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/ab89f1","article-title":"Design of an innovative platform for the treatment of cerebral tumors by means of erythro-magneto-HA-virosomes","volume":"6","author":"Lucarini","year":"2020","journal-title":"Biomed. Phys. Eng. Express"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0945","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(95)11503-O","article-title":"Sendai virosomal infusion of an adeno-associated virus-derived construct containing neuropeptide Y into primary rat brain cultures","volume":"190","author":"Wu","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0950","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-9516-5_11","article-title":"Bioconjugation in drug delivery: practical perspectives and future perceptions","author":"Elzahhar","year":"2019"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0955","doi-asserted-by":"crossref","first-page":"E1167","DOI":"10.1152\/ajpendo.00193.2003","article-title":"Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier","volume":"285","author":"O\u2019Kane","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0960","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1471-4159.1993.tb13428.x","article-title":"Identification of the cationic amino acid transporter (system y+) of the rat blood-brain barrier","volume":"60","author":"Stoll","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0965","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/physrev.00022.2002","article-title":"Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells","volume":"83","author":"Mann","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0970","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2016.01.041","article-title":"Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting","volume":"141","author":"Li","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.02.015_bb0975","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1021\/acs.molpharmaceut.7b00569","article-title":"Large amino acid transporter 1 selective liposomes of l -DOPA functionalized amphiphile for combating glioblastoma","volume":"14","author":"Bhunia","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0980","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/slct.201903722","article-title":"Design, synthesis and biological evaluation of triptorelin analogs containing tetrazole moiety","volume":"5","author":"Sohbati","year":"2020","journal-title":"ChemistrySelect."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0985","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0885328220949367","article-title":"RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells","volume":"35","author":"Mahmoudi","year":"2021","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0990","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2018.07.042","article-title":"Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier","volume":"123","author":"M\u00e9sz\u00e1ros","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb0995","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","article-title":"A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs","volume":"460","author":"Ishida","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1000","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0005-2736(01)00357-1","article-title":"In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach","volume":"1513","author":"Iden","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/1061186X.2014.888070","article-title":"Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood\u2013brain barrier in rats","volume":"22","author":"Rip","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1010","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3892\/ol.2014.2449","article-title":"A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy","volume":"8","author":"Qin","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1015","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/10717544.2018.1494223","article-title":"Enhanced blood\u2013brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles","volume":"25","author":"Liang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1020","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1038\/srep12651","article-title":"Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1025","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1016\/j.biomaterials.2009.08.049","article-title":"Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"30","author":"Ke","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","article-title":"Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2","volume":"155","author":"R\u00e9gina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2010.05.017","article-title":"Uptake and intracellular release kinetics of liposome formulations in glioma cells","volume":"395","author":"Bellavance","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biomaterials.2011.10.035","article-title":"Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome","volume":"33","author":"Sun","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.07.021","article-title":"Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery","volume":"419","author":"Qin","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresbull.2018.08.003","article-title":"Ligand conjugation: an emerging platform for enhanced brain drug delivery","volume":"142","author":"Nabi","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2011.09.008","article-title":"Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals","volume":"420","author":"Qin","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.nano.2011.05.004","article-title":"Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model","volume":"7","author":"Re","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1065","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.nano.2013.12.001","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A\u03b2 aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease","volume":"10","author":"Bana","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1070","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/jps.23152","article-title":"Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model","volume":"101","author":"Sharma","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/anticanres.13103","article-title":"Cell-penetrating peptide-coated liposomes for drug delivery across the blood-brain barrier","volume":"39","author":"Yuan","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","article-title":"Liposome-based glioma targeted drug delivery enabled by stable peptide ligands","volume":"218","author":"Wei","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1085","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/ijms17121998","article-title":"Enhancing anticancer effect of gefitinib across the blood-brain barrier model using liposomes modified with one \u0251-helical cell-penetrating peptide or glutathione and Tween 80","volume":"17","author":"Lin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1090","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1038\/s41598-019-45137-8","article-title":"gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery","volume":"9","author":"Iachetta","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1095","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1039\/C9NR03931G","article-title":"Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier","volume":"11","author":"Shi","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1100","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2147\/IJN.S131367","article-title":"A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood\u2013brain barrier, and the transporting mechanism to glioma cells","volume":"12","author":"Liu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2018.07.043","article-title":"Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection","volume":"286","author":"dos Santos Rodrigues","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1110","doi-asserted-by":"crossref","first-page":"29977","DOI":"10.1021\/acsami.6b10146","article-title":"Liposome-based systemic glioma-targeted drug delivery enabled by all- d peptides","volume":"8","author":"Ying","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1115","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1002\/jps.24186","article-title":"Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT","volume":"103","author":"Zong","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood-brain barrier for effective treatment of Alzheimer\u2019s disease","volume":"18","author":"Arora","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1125","doi-asserted-by":"crossref","first-page":"33378","DOI":"10.1039\/C7RA05071B","article-title":"Tumor homing and penetrating peptide-conjugated niosomes as multi-drug carriers for tumor-targeted drug delivery","volume":"7","author":"Ag Seleci","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/000000006783980946","article-title":"TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice","volume":"16","author":"Gupta","year":"2007","journal-title":"Oncol. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","article-title":"A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson\u2019s disease","volume":"277","author":"Qu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006948027674","article-title":"Transferrin and transferrin receptor function in brain barrier systems","volume":"20","author":"Moos","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/aps.2009.199","article-title":"Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations","volume":"31","author":"Le Gao","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0939-6411(01)00159-X","article-title":"Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: implications for drug delivery","volume":"52","author":"Fischer","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1155","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/mp800218q","article-title":"Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals","volume":"6","author":"Du","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejps.2005.03.008","article-title":"Targeting liposomes with protein drugs to the blood-brain barrier in vitro","volume":"25","author":"Visser","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1165","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate alzheimer\u2019s disease-related pathology in APP\/PS-1 mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1170","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/acsbiomaterials.0c01113","article-title":"The blood-brain barrier cell-targeted gene delivery system to enhance nerve growth factor protein secretion in the brain","volume":"6","author":"Wu","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1175","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","article-title":"Glioma targeting and blood-brain barrier penetration bydual-targeting doxorubincin liposomes","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1180","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2217\/nnm.14.27","article-title":"Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies","volume":"9","author":"Loureiro","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.colsurfb.2015.06.067","article-title":"Dual ligand immunoliposomes for drug delivery to the brain","volume":"134","author":"Loureiro","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1476-4598-13-191","article-title":"OX26\/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma","volume":"13","author":"Yue","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1195","first-page":"1749","article-title":"Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-\u03b2 peptide: the chemical design affects the permeability across an in vitro model","volume":"8","author":"Salvati","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1200","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1517\/13543784.2012.703177","article-title":"Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions","volume":"21","author":"Patel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1205","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.WCB.0000135592.28823.47","article-title":"Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion","volume":"24","author":"Gosk","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2019.01.005","article-title":"Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo","volume":"295","author":"Johnsen","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJN.S23771","article-title":"Investigation of glucose-modifed liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting","volume":"7","author":"Xie","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0076-6879(03)73032-8","article-title":"Gene targeting in vivo with pegylated immunoliposomes","volume":"373","author":"Pardridge","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1225","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11095-007-9357-6","article-title":"Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer","volume":"25","author":"Zhang","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1602\/neurorx.2.1.99","article-title":"Drug transport to brain with targeted liposomes","volume":"2","author":"Schnyder","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1061186X.2019.1648479","article-title":"Liposome\u2013ligand conjugates: a review on the current state of art","volume":"28","author":"Ero\u011flu","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1255","series-title":"Drug Delivery Aspects","first-page":"19","article-title":"Preclinical testing\u2014understanding the basics first - ScienceDirect","author":"Shegokar","year":"2020"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1260","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.drudis.2021.04.008","article-title":"Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors","volume":"26","author":"Reddy","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-02144-1","article-title":"Multi-disciplinary approach for drug and gene delivery systems to the brain","volume":"23","author":"Ndemazie","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1270","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","article-title":"Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status","volume":"65","author":"van der Meel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1285","year":"2014","journal-title":"Patients"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1305","author":"Katz (Shai)"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1310","first-page":"1","article-title":"Nanocarriers for Alzheimer\u2019s disease: research and patent update","volume":"11","author":"Pathak","year":"2021","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1315","author":"Micklus"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1320","author":"Pardrige"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1325","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/(SICI)1097-4547(20000315)59:6<712::AID-JNR3>3.0.CO;2-L","article-title":"Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor","volume":"59","author":"Soilu-H\u00e4nninen","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1330","article-title":"1\u03b1,25-Dihydroxyvitamin D 3enhances cerebral clearance of human amyloid-\u03b2 peptide(1-40) from mouse brain across the blood-brain barrier","volume":"8","author":"Ito","year":"2011","journal-title":"Fluids Barr. CNS"},{"key":"10.1016\/j.jconrel.2022.02.015_bb1335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1461145711001611","article-title":"The effect of rosiglitazone on LRP1 expression and amyloid \u03b2 uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment","volume":"15","author":"Moon","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1345","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1350","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","article-title":"Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme","volume":"10","author":"Jena","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.02.015_bb1355","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater. Today"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:40:54Z","timestamp":1777509654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592200089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":263,"alternative-id":["S016836592200089X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.015","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}